Western blot denoted that by contrast to FHC cells, CRC cells (HT-29, DLD-1, LS513, LoVo, HCT15) had enhanced IGF2BP2 protein level (P < 0.05, Figure 1(g-h)). The gene discussed is IGF2BP2; the disease is colorectal carcinoma.